Skip to main content
Clinical Trials/CTRI/2022/06/043478
CTRI/2022/06/043478
Not yet recruiting
未知

To evaluate the invivo safety and efficacy of the skin care formulation in terms of sweat resistance on healthy human subjects

Sun Pharmaceutical Industries Limited0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Sun Pharmaceutical Industries Limited
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\.Indian male \& female subjects
  • 2\.Healthy subjects (no infectious and evolutive pathology which could make the subject vulnerable and stop the study, no pathology which could interfere with the study, no symptom in the process of an exploratory checkup)
  • 3\.Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scarââ?¬Â¦.)
  • 4\.Being able to produce at least 100 mg of sweat and whose left versus right half face sweat is more or less the same
  • 5\.Having shaved beard two days before study visit.

Exclusion Criteria

  • 1\.For Females: Being pregnant or breastfeeding or having stopped to breastfeed in the past three months.
  • 2\.Having refused to give his/her assent by not signing the consent form
  • 3\.Taking part in another study liable to interfere with this study
  • 4\.Being insulin\-dependent diabetic or non\-insulin\-dependent diabetic with a recent therapy (less than 6 months)
  • 5\.Having sensitive or dry skin \& acne prone skin.
  • 6\.Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 months)
  • 7\.Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products or food products.
  • 8\.Following a chronic medicinal treatment comprising any of the following products: aspirin\-based products, anti\-inflammatories, anti\-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol).
  • 9\.Having cutaneous hypersensitivity.
  • 10\.Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months.

Outcomes

Primary Outcomes

Not specified

Similar Trials